Introduction
Temporal lobe epilepsy (TLE) is the most frequent and drugresistant syndrome among the refractory focal epilepsy syndromes. Over the last few decades epilepsy surgery has proved to be a successful and effective method for the treatment of patients with medically refractory temporal lobe epilepsy providing 60-70% freedom from disabling seizures. 1 The aim of surgical treatment is to achieve seizure freedom with the smallest possible postsurgical neuropsychological deficit. In many epilepsy centres selective amygdalohippocampectomy via the transsylvian route was established as a common surgical procedure for treatment of temporal lobe epilepsies 2 since it appears to have more favourable cognitive outcome compared with standard anterior temporal lobectomy. 3, 4 However, restrictive operation types can reduce the efficiency of seizure control. Insufficient removal of the epileptogenic zone, multifocal epileptic discharges caused by an extended network within the ipsilateral hemisphere 5 or an independent contralateral temporal epileptogenic zone 6 can lead to an unsatisfying outcome after epilepsy surgery. Up to 40% of the patients relapse, either immediately or at a later time after surgery. 6, 7 A reoperation using an extended resection type, like anteromedial temporal lobectomy, can be a treatment option for patients with persistent seizures postoperatively.
The aim of the present study was to examine the postoperative outcome in temporal lobe epilepsy patients who underwent reoperation after a failed epilepsy surgery. We systematically analyzed the results of comprehensive preoperative evaluations (demographic data, ictal and interictal discharges on scalp EEG, Seizure 22 (2013) [502] [503] [504] [505] [506] seizure semiology, magnetic resonance imaging, neuropsychological test-results) before the first surgery, and before and after reoperation. In addition, we attempted to determine what factors, if any, might predict a successful outcome after reoperation.
Methods

Patients
We retrospectively analyzed the data of patients who were evaluated and operated at our institution between 1993 and 2010. The inclusion criteria were medically intractable temporal lobe epilepsy, no evidence of malignant brain tumour and a follow-up period for outcome classification of at least 12 months.
Between December 1993 and December 2011, 487 surgical interventions for the management of epilepsy were performed at our institution. Three hundred and thirty six patients (152 male, 184 female) underwent resective epilepsy surgery for medically refractory TLE, 146 patients underwent selective amygdalohippocampectomy (sAHE), 113 patients had anteromedial temporal lobectomy (AMT) and 77 had tailored temporal lobe resection (TR).
Two hundred and forty four patients (72.6%) were free of disabling seizures (Class 1a to Class 2 according to Wieser's classification 8 ) at least 12 month before observation points.
All patients who had persistent seizures after the first epilepsy surgery (Class 3-Class 5 according to Wieser's classification) were offered a re-evaluation and, if possible, reoperation. We excluded from further analysis patients who refused re-evaluation (47 patients), or reoperation (12 patients) and patients with incomplete data or lost follow-up (16 patients) data after reoperation. In the end, 17 patients (6 male, 11 female) who underwent reoperation after an extensive re-evaluation were included in subsequent analyses. The protocol of the study was reviewed and approved by local Ethics Committee.
Presurgical evaluation
All patients were subjected to extensive evaluation before surgery. The presurgical work-up comprised neurologic examination and history, prolonged Video-EEG-monitoring, high resolution magnetic resonance imaging (MRI), Wada-testing for assessment of language and memory functions, formal neuropsychological testing and visual field examination using the standard automated perimetry exam. In the majority of patients interictal single photon emission computed tomography (SPECT) and interictal positron emission tomography (PET) were performed.
Video-EEG-monitoring was recorded for an average of 5 days; the EEG was recorded according to the extended International 10-20 System including bilaterally placed sphenoidal electrodes. Seizure semiology and clinical lateralizing signs during the seizures were evaluated with respect to prediction of the side of the epileptogenic zone. 9 Absolute spike frequency and location of interictal epileptiform discharges (IEDs) were assessed by visual analyses over the entire recording time. The distribution of IEDs was defined as unilateral if >90% of spikes occurred over the affected temporal lobe. 10 Ictal scalp EEG patterns were determined by morphology, location and time course of ictal EEG changes.
11,12
The results of Video-EEG-monitoring were considered congruent if the patient had ipsilateral unitemporal IEDs, ipsilateral temporal ictal EEG patterns and clinical lateralizing signs corresponding to ipsilateral temporal region or non-lateralizable signs clearly corresponding to temporal lobe origin, i.e. oral automatisms, behavioural arrest, etc. The results were considered incongruent if one of the following was applicable: IED distribution was bitemporal or predominantly contralateral, ictal EEG patterns could not be clearly localized over the affected temporal lobe and the clinical ictal semiology was lateralized to contralateral side. All patients underwent a high-resolution MRI scan using a 1.5 T machine (Philips Gyroscan ACS-NT; Best the Netherlands). Starting from 2006 MRI was carried out on a 3.0 T machine. A temporal lobe protocol was applied for detailed depiction of temporal lobe structures (guidelines for neuroimaging evaluation of patients with uncontrolled epilepsy considered for surgery). 13 
Surgical procedure
Depending on the results of the comprehensive preoperative evaluations, the patients were subjected to following surgical procedures: selective amygdalohippocampectomy, anteromedial temporal lobectomy or tailored temporal lobe resection. The decision regarding the type of operation to be performed was made individually for each patient after completing the presurgical work-up and case discussion at a multidisciplinary epilepsy conference. All surgeries were done by one neurosurgeon (T.C.) between 1993 and 2010. The resected tissue was sent for histopathological analyses in all cases.
Postoperative outcome
The postoperative follow-up was assessed one, two, five and 10 years postoperatively. It included neurological examination, scalp EEG, MRI, neuropsychological testing and visual field examination. In addition, the seizure outcome was evaluated yearly based on telephone interviews. The outcome was scored using the stringent classification of the International League Against Epilepsy. 8 Overall from 336 operated patients 244 patients (72.6%) were free of disabling seizures (ILAE Classes 1a, 1 and 2): 109 patients with sAHE (74.7%), 80 patients with AMT (70.8%) and 55 patients with TR (71.4%). These results are presented in Table 1 . The patients who failed after the first operation were offered a reevaluation according to criteria described above and, if possible, a reoperation. Again, the decision regarding the type of reoperation to be performed was made individually after completing the reevaluation and case discussion at a multidisciplinary epilepsy conference. After the reoperation the patients were subjected to postoperative follow-up using the same criteria that were used after the initial operation.
Analysis of the data of reoperated patients
Only reoperated patients were included in subsequent analysis. We preformed an analysis of different variables in order to assess prognostic significance and to find the best predictors for successful outcome. These variables included history of febrile seizures, TBI, infectious brain diseases, perinatal pathology, morphological changes on MRI, concordance of results of Video-EEG-monitoring with side of operation, type and extent of operation and histopathology. The statistical analysis of the data was performed using commercially available statistical software (SPSS 19.0; Chicago, IL). Demographic and clinical characteristics of patients were compared using Fisher's exact tests for ordinal and two-sided Students' t-tests for metrical data. The level of significance was set to p < 0.05.
Results
The clinical data of the 17 reoperated patients are summarized in the Table 2 . The mean age at seizure onset was 9.4 years (range 0.1-36 years; median 6 years), the mean duration of epilepsy was 21.7 years (range 5-48 years; median 20.9 years) and the mean age at first operation was 31.1 years (range 16-61 years; median 29 years). Two patients without morphological changes on MRI before first operation (patients #4 and #6) underwent invasive evaluation. The seizures reoccurred immediately after first operation in all patients except of one patient (patient #8) in whom the seizures occurred 12 month after first operation. There was no change in antiepileptic drug regimen after first operation. The antiepileptic drugs were kept stable at least 12 month after operation. The mean age at the time of reoperation was 35.5 years (range 18-65 years; median 34 years).
Overall, 13 of 17 patients (76.5%) improved after reoperation: five patients (29.4%) were completely seizure free after reoperation (Class 1a) (median duration 60 months, range 12-72); six patients (35.3%) were seizure free at least 12 month before observation points (median duration 120.5 months, range 35-155) and two patients (11.8%) had a decrease in seizure frequency. Four patients (23.5%) remained unchanged with respect to seizure frequency and severity (Table 3) .
Patients who had no history of TBI improved after reoperation, compared to patients who had a history of TBI (p = 0.044). There was no correlation between improvement in seizure outcome after reoperation and the following variables: gender (p = 0. 
results. Two patients with congruent Video-EEGmonitoring results before first operation developed bilateral spike distribution after surgery. This resulted in the incongruent Video-EEG-monitoring results before reoperation. Patient #6 had bilateral spike distribution with 18% interictal spikes localized to contralateral temporal lobe and patient #17 had 29% of interictal spikes on the contralateral temporal lobe. The ictal EEG patterns and clinical semiology were congruent to side of operation (Supporting information 1).
Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/ j.seizure.2012.11.011.
We also analyzed the neuropsychological test results before and after surgery, and after reoperation. The patients were administered standardized neuropsychological tests prior to surgery, 38 months mean (range from 3 to 96 months) postoperatively and again 49 months mean (range from 9 to 120) after reoperation. Only tasks that were administered to most of the patients were included. Although the majority of patients received a similar battery of tests, there were some discrepancies. This was due to varying presenting cognitive complaints at the time of testing and alterations in the standard test battery over the 15-year period. For this reason the presented results are rather descriptive. Patients who were seizure-free after reoperation tended to score higher on HAWIE Verbal and Performance IQ measures than those who were not seizure-free (p = 0.018). Mean IQ scores for both patient groups, however, fell within the average range. The seizure-free patients tended to perform better on verbal fluency tests (p = 0.009) although reliable between-group statistical comparisons of mean scores were not possible due to small and unequal sample sizes (Supporting information 2).
Discussion
Epilepsy surgery is the most efficacious therapeutic modality for patients with medically refractory focal epilepsies. Ideal candidates for epilepsy surgery are patients with mesial TLE with ipsilateral spikes, seizure onset pattern, clinical lateralizing signs and atrophy of mesial structures on MRI.
14,15 Nevertheless, surgical failures remain a challenge to the epilepsy treatment team with long term seizure-free outcome and success rates ranging from 45% (five years outcome) to 70%. 1, 7, [16] [17] [18] Our findings indicate that reoperation can considerably improve the operative outcome of the first failed epilepsy surgery in patients with drug resistant temporal lobe epilepsies. While many epilepsy centres have started to report their experience with the management of recurrent seizures and reoperation after failure of initial surgery, [19] [20] [21] [22] [23] [24] [25] there remains a lack of information about outcome data in the literature and reoperation still remains rare in epilepsy surgery. The present study also attempted to determine prognostic factors in failed temporal lobe epilepsy surgeries. After systematic analyses of the results of comprehensive evaluation before the first surgery and before and after reoperation we found that patients who improved after reoperation had no history o f TBI compared to patients who did not improve (p = 0.044). Although the significance of this finding remains unknown, it may suggest that traumatic brain injury could cause spatial extension of the epileptogenic zone. Due to very small number of patients these results should be treated with caution.
Other predictors of postoperative seizure outcome have been discussed in recent publications. Anatomically and electrographically non-localized seizure onset before the first operation has been considered a negative predictor for reoperation recommending palliative procedures unless there is compelling evidence that reoperation will be successful. 23 Schulz et al. discuss an association between ictal scalp EEG with secondary contralateral independent EEG seizure propagation patterns, small quantity of lateral temporal lobe resection and non-favourable outcome after second surgery in patients with mesial TLE. 22 This suggests that the remaining epileptogenc tissue near the anterior or posterior hippocampal commissures and propagation of epileptic activity could be a possible reason for contralateral EEG propagation that may result in a non-favourable outcome. This hypothesis can be confirmed only by using invasive Video-EEG monitoring, which is the 'gold standard' for defining the epileptogenic zone. Although we did not use invasive monitoring in patients before reoperation, the postoperative seizure outcome of patients with incongruent Video-EEG results before the first surgery (p = 0.116) and before reoperation (p = 0.622) was not poorer compared to patients with congruent Video-EEG results. Additional studies using invasive Video-EEG monitoring would be required to strengthen these findings. We did not find any correlation of other investigated demographic and clinical data (sex, handedness, positive family history for epilepsy, history of infection, history of febrile seizures, age at the first operation and at reoperation, type of operation for first operation (sAHE vs. TR) and reoperation (sAHE vs. AMT), histopathological results of first operation and reoperation) with postoperative seizure-freedom after reoperation.
Even though our centre was established 1993 when preoperative structural imaging using MRI was a standard procedure in phase I of evaluation, we do not exclude the possibility that our series of patients could have had an inadequate resection at the time of the first surgery. The results of MRI analysis of the reoperated patients are already presented in a previous study, showing residual mesiotemporal structures in the majority of patients who became seizure free after reoperation. 25 Nevertheless in our series of 336 patients operated on temporal lobe the seizure outcome of patients with sAHE is even slightly better in comparison to large resections: 74.7% of patients with sAHE, 70.8% of patients with AMT and 71.4% of patients with TR are free of disabling seizures postoperatively. The philosophy of our centre is to restrict the resection to the smallest possible area to reduce the chance of postoperative neuropsychological deficits. 3 The aim of present study was an attempt to persuade for proceeding to reoperation after failure of first operation. Encouraging are also the results of neuropsychological testing showing that patients who were seizure-free after reoperation tended to score higher on HAWIE Verbal and Performance IQ measures than those that were not seizure-free (p = 0.018). The seizure-free patients tended to perform better on verbal fluency tests (p = 0.009) although reliable between-group statistical comparisons of mean scores were not possible due to small and unequal sample sizes.
Our overall seizure-free outcome of reoperated patients of 64.7% is higher in comparison to previously published studies, where the rate of seizure-free patients ranged from 19 to 57%. [20] [21] [22] [23] [24] This could be due to our very careful selection of patients with regard to localization and type of lesion. The majority of previous studies included different aetiologies of epilepsies (lesional and non-lesional) and mostly mixed localization (temporal and extratemporal cases). Moreover, other studies focused on the neurosurgical approach to define and resect residual mesial temporal lobe structures and in some cases a corpus callosotomy or even VNS were considered a reoperation. [20] [21] [22] [23] [24] To our knowledge this is the first study with systematic analyses of reoperated patients with temporal lobe epilepsies, who mostly underwent sAHE or tailored very restricted AMT during the first operation. Although the search for clinical predictors of surgical failures has shown limited success, our study demonstrated that a favourable outcome appeared in patients without TBI. Even though our sample size is small, these initial results are very promising.
Conclusions
Overall 76.5% of patients (13 of 17) in our series improved after further surgery. Our data confirm prior literature suggesting that a reoperation may result in a considerable improvement of the operative outcome of the first failed epilepsy surgery. Epilepsy centres should be encouraged to report the results of failed epilepsy surgery.
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